US Meningitis Diagnosis and Treatment Market

ID: MRFR/Pharma/17372-HCR
100 Pages
Satyendra Maurya
Last Updated: April 06, 2026
US Meningitis Diagnosis and Treatment Market Research Report: Size, Share, Trend Analysis By Diagnosis Method (Lumbar Puncture, Blood Cultures, Polymerase Chain Reaction, Imaging Techniques, Serological Tests), By Treatment Type (Antibiotics, Corticosteroids, Vaccines, Supportive Care, Antiviral Medication), By Pathogen Type (Bacterial Meningitis, Viral Meningitis, Fungal Meningitis, Parasitic Meningitis) and By End Users (Hospitals, Diagnostic Laboratories, Research Institutions) - Growth Outlook & Industry Forecast 2025 To 2035
US Meningitis Diagnosis and Treatment Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)3.11%
2024 Market Size$ 930.3 Million
2025 Market Size$ 959.23 Million
2035 Market Size$ 1,302.96 Million
Key Players
Pfizer Inc
Merck & Co Inc
GlaxoSmithKline plc
Sanofi S.A.
Baxter International Inc
Novartis AG
Trends
  • Advancements in Diagnostic Technologies
  • Increased Vaccine Development
  • Growing Public Health Awareness
Opportunities
  • Rising Incidence of Meningitis Cases
  • Regulatory Support for New Treatments
  • Growing Demand for Preventive Healthcare
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Medical Device, BY Diagnosis Method (USD Million)
      1. 4.1.1 Lumbar Puncture
      2. 4.1.2 Blood Cultures
      3. 4.1.3 Polymerase Chain Reaction
      4. 4.1.4 Imaging Techniques
      5. 4.1.5 Serological Tests
    2. 4.2 Medical Device, BY Treatment Type (USD Million)
      1. 4.2.1 Antibiotics
      2. 4.2.2 Corticosteroids
      3. 4.2.3 Vaccines
      4. 4.2.4 Supportive Care
      5. 4.2.5 Antiviral Medication
    3. 4.3 Medical Device, BY Pathogen Type (USD Million)
      1. 4.3.1 Bacterial Meningitis
      2. 4.3.2 Viral Meningitis
      3. 4.3.3 Fungal Meningitis
      4. 4.3.4 Parasitic Meningitis
    4. 4.4 Medical Device, BY End User (USD Million)
      1. 4.4.1 Hospitals
      2. 4.4.2 Diagnostic Laboratories
      3. 4.4.3 Research Institutions
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Medical Device
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Medical Device
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Pfizer Inc (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Merck & Co Inc (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 GlaxoSmithKline plc (GB)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Sanofi S.A. (FR)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Baxter International Inc (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Novartis AG (CH)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 AstraZeneca plc (GB)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Roche Holding AG (CH)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 US MARKET ANALYSIS BY DIAGNOSIS METHOD
    3. 6.3 US MARKET ANALYSIS BY TREATMENT TYPE
    4. 6.4 US MARKET ANALYSIS BY PATHOGEN TYPE
    5. 6.5 US MARKET ANALYSIS BY END USER
    6. 6.6 KEY BUYING CRITERIA OF MEDICAL DEVICE
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF MEDICAL DEVICE
    9. 6.9 DRIVERS IMPACT ANALYSIS: MEDICAL DEVICE
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: MEDICAL DEVICE
    11. 6.11 SUPPLY / VALUE CHAIN: MEDICAL DEVICE
    12. 6.12 MEDICAL DEVICE, BY DIAGNOSIS METHOD, 2024 (% SHARE)
    13. 6.13 MEDICAL DEVICE, BY DIAGNOSIS METHOD, 2024 TO 2035 (USD Million)
    14. 6.14 MEDICAL DEVICE, BY TREATMENT TYPE, 2024 (% SHARE)
    15. 6.15 MEDICAL DEVICE, BY TREATMENT TYPE, 2024 TO 2035 (USD Million)
    16. 6.16 MEDICAL DEVICE, BY PATHOGEN TYPE, 2024 (% SHARE)
    17. 6.17 MEDICAL DEVICE, BY PATHOGEN TYPE, 2024 TO 2035 (USD Million)
    18. 6.18 MEDICAL DEVICE, BY END USER, 2024 (% SHARE)
    19. 6.19 MEDICAL DEVICE, BY END USER, 2024 TO 2035 (USD Million)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY DIAGNOSIS METHOD, 2025-2035 (USD Million)
      2. 7.2.2 BY TREATMENT TYPE, 2025-2035 (USD Million)
      3. 7.2.3 BY PATHOGEN TYPE, 2025-2035 (USD Million)
      4. 7.2.4 BY END USER, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

US Meningitis Diagnosis and Treatment Market Segmentation

US Meningitis Diagnosis and Treatment Market By Diagnosis Method (USD Million, 2025-2035)

  • Lumbar Puncture
  • Blood Cultures
  • Polymerase Chain Reaction
  • Imaging Techniques
  • Serological Tests

US Meningitis Diagnosis and Treatment Market By Treatment Type (USD Million, 2025-2035)

  • Antibiotics
  • Corticosteroids
  • Vaccines
  • Supportive Care
  • Antiviral Medication

US Meningitis Diagnosis and Treatment Market By Pathogen Type (USD Million, 2025-2035)

  • Bacterial Meningitis
  • Viral Meningitis
  • Fungal Meningitis
  • Parasitic Meningitis

US Meningitis Diagnosis and Treatment Market By End User (USD Million, 2025-2035)

  • Hospitals
  • Diagnostic Laboratories
  • Research Institutions

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.